11 – 20 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
- Contribution to journal › Article
-
Mark
APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β
- Contribution to journal › Debate/Note/Editorial
-
Mark
Alzheimer Disease Blood Biomarkers in Patients with Out-of-Hospital Cardiac Arrest
- Contribution to journal › Article
- 2022
-
Mark
One-Year Outcome Trajectories and Factors Associated with Functional Recovery among Survivors of Intracerebral and Intraventricular Hemorrhage with Initial Severe Disability
- Contribution to journal › Article
-
Mark
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal with Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment
- Contribution to journal › Article
-
Mark
Research Criteria for the Behavioral Variant of Alzheimer Disease : A Systematic Review and Meta-analysis
- Contribution to journal › Scientific review
-
Mark
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
- Contribution to journal › Article
-
Mark
Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
- Contribution to journal › Article
- 2021
-
Mark
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease : A Head-to-Head Comparison against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging
- Contribution to journal › Article
-
Mark
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- Contribution to journal › Article
